Skip to main content

Randal Kirk

Equibles does not estimate personal net worth.

Get an email with a short summary when Precigen, Inc. publishes a filing, an earnings call transcript or a press release.

Get PGEN alerts

About Randal Kirk

Randal Kirk is recorded as Board Member at Precigen, Inc. (PGEN) since June 26, 2025 and Chairman at Precigen, Inc. (PGEN). The newest filing on record that lists Randal Kirk as Chairman at Precigen, Inc. (PGEN) is dated April 28, 2021. The proxy statement of Precigen, Inc. reports total compensation of $2,067,617 for Randal Kirk in fiscal 2019. Disclosed compensation is on record for 3 fiscal years. Precigen, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Precigen, Inc. includes Helen Sabzevari (CEO and Board Member), Helen Sabzevari, Ph.D. (CEO), Randal J. Kirk (Chairman and Board Member) and 7 others.

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Chairman, Board Member

2025-06-26–present

Leadership on record at Precigen, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2019 Precigen, Inc. (PGEN) — $2,067,617
2018 Precigen, Inc. (PGEN) — $2,056,450
2017 Precigen, Inc. (PGEN) — $1,907,879

Recent activity

No call appearances or filed executive changes recorded yet.